Scientific Publications
Our science is rooted in evidence-based, peer-reviewed research.
Read from our library.
Publications
Bifidobacterium infantis EVC001 Administration Is Associated With a Significant Reduction In Incidence of Necrotizing Enterocolitis In Very Low Birth Weight Infants
Impact of Probiotic Bifidobacteria infantis EVC001 Feeding in Premature Infants on the Gut Microbiome, Nosocomially Acquired Antibiotic Resistance, and Enteric Inflammation
B. infantis EVC001 Is Well-Tolerated and Improves Human Milk Oligosaccharide Utilization in Preterm Infants in the Neonatal Intensive Care Unit
Symptomatic relief from at-home use of activated Bifidobacterium infantis EVC001 probiotic in infants:
Metagenomic insights of the infant microbiome community structure and function across multiple sites in the United States
Comparative Genome Analysis of Bifidobacterium longum subsp. infantis Strains Reveals Variation in Human Milk Oligosaccharide Utilization Genes among Commercial Probiotics
Colonization by Bifidobacteria infantis EVC001 modulates enteric inflammation in exclusively breastfed infants
Persistence of Supplemented Bifidobacterium longum subsp. infantis EVC001 in Breastfed Infants
Early-life gut microbiome modulation reduces the abundance of antibiotic-resistant bacteria
Reduced colonic mucin degradation in breastfed infants colonized by Bifidobacterium longum subsp. infantis EVC001
Bifidobacterium infantis EVC001 Administration Is Associated With a Significant Reduction In Incidence of Necrotizing Enterocolitis In Very Low Birth Weight Infants
Bifidobacterium infantis EVC001 Administration Is Associated With a Significant Reduction In Incidence of Necrotizing Enterocolitis In Very Low Birth Weight Infants
Featured News Coverage
Our breakthrough findings on B. infantis EVC001 and its impacts on infant health have been addressed in notable publications around the world.